Posted April 24, 2020
The agency is delaying deployment of serological testing with more red tape. When will this end? Action Alert! The FDA is blocking COVID-19 testing at point-of-care facilities such as doctors’ offices and clinics, and instead insisting that, in many cases, they be performed at “high complexity labs,” of which there are only a very few nationwide. This is yet another unfortunate example of the FDA’s complete lack of flexibility during the COVID-19 pandemic. Read more.